Evidence map›Paper›PMID 22960744›Full record

ArticleNature2012

The yeast Fun30 and human SMARCAD1 chromatin remodellers promote DNA end resection.

Thomas Costelloe, Raphaël Louge, Nozomi Tomimatsu, Bipasha Mukherjee, Emmanuelle Martini, Basheer Khadaroo, Kenny Dubois, Wouter W Wiegant, Agnès Thierry, Sandeep Burma and 2 more

Abstract read
In one paragraph

Article in Nature, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 177 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
177citing papers in PubMed, 1 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

177 citing papers in PubMed, 1 synthesis or guideline pooled it, 270 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Role of Arp2/3 in End-Resection During DNA Double-Strand Break Repair.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

117 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Thomas CostelloeDepartment of Toxicogenetics, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands.
Raphaël Louge
Nozomi Tomimatsu
Bipasha Mukherjee
Emmanuelle Martini
Basheer Khadaroo
Kenny Dubois
Wouter W Wiegant
Agnès Thierry
Sandeep Burma
Haico van Attikum
Bertrand Llorente
Centre National de la Recherche Scientifique · FRLeiden University · NLRadiation Oncology Associates · USCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRInstitut Pasteur · FR

Funding

Molecular mechanisms of GBM radioresistance and strategies for radiosensitizationR01CA149461 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BURMA, SANDEEP · 2011 to 2015
$1.6M
NCI NIH HHS R01 CA149461
6 · The paper itself

Abstract

Several homology-dependent pathways can repair potentially lethal DNA double-strand breaks (DSBs). The first step common to all homologous recombination reactions is the 5'-3' degradation of DSB ends that yields the 3' single-stranded DNA required for the loading of checkpoint and recombination proteins. In yeast, the Mre11-Rad50-Xrs2 complex (Xrs2 is known as NBN or NBS1 in humans) and Sae2 (known as RBBP8 or CTIP in humans) initiate end resection, whereas long-range resection depends on the exonuclease Exo1, or the helicase-topoisomerase complex Sgs1-Top3-Rmi1 together with the endonuclease Dna2 (refs 1-6). DSBs occur in the context of chromatin, but how the resection machinery navigates through nucleosomal DNA is a process that is not well understood. Here we show that the yeast Saccharomyces cerevisiae Fun30 protein and its human counterpart SMARCAD1 (ref. 8), two poorly characterized ATP-dependent chromatin remodellers of the Snf2 ATPase family, are directly involved in the DSB response. Fun30 physically associates with DSB ends and directly promotes both Exo1- and Sgs1-dependent end resection through a mechanism involving its ATPase activity. The function of Fun30 in resection facilitates the repair of camptothecin-induced DNA lesions, although it becomes dispensable when Exo1 is ectopically overexpressed. Interestingly, SMARCAD1 is also recruited to DSBs, and the kinetics of recruitment is similar to that of EXO1. The loss of SMARCAD1 impairs end resection and recombinational DNA repair, and renders cells hypersensitive to DNA damage resulting from camptothecin or poly(ADP-ribose) polymerase inhibitor treatments. These findings unveil an evolutionarily conserved role for the Fun30 and SMARCAD1 chromatin remodellers in controlling end resection, homologous recombination and genome stability in the context of chromatin.

Indexed as

Chromatin Assembly and DisassemblyDNA Breaks, Double-StrandedDNA RepairCamptothecinCell LineCell SurvivalDNADNA HelicasesExodeoxyribonucleasesGenomic InstabilityHistonesHomologous RecombinationHumansMutationNucleosomesPoly(ADP-ribose) Polymerase InhibitorsCamptothecinDNADNA Helicasesexodeoxyribonuclease IExodeoxyribonucleasesFUN30 protein, S cerevisiaeHistonesNucleosomesPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesRecQ HelicasesSaccharomyces cerevisiae ProteinsSGS1 protein, S cerevisiaeSMARCAD1 protein, humanTranscription Factors

Identifiers

PMID22960744
PMCPMC3493121
OpenAlexW2145506563

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.